Does GILTERITINIB Cause Multiple organ dysfunction syndrome? 44 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Multiple organ dysfunction syndrome have been filed in association with GILTERITINIB (Xospata). This represents 1.2% of all adverse event reports for GILTERITINIB.
44
Reports of Multiple organ dysfunction syndrome with GILTERITINIB
1.2%
of all GILTERITINIB reports
38
Deaths
26
Hospitalizations
How Dangerous Is Multiple organ dysfunction syndrome From GILTERITINIB?
Of the 44 reports, 38 (86.4%) resulted in death, 26 (59.1%) required hospitalization, and 15 (34.1%) were considered life-threatening.
Is Multiple organ dysfunction syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GILTERITINIB. However, 44 reports have been filed with the FAERS database.
What Other Side Effects Does GILTERITINIB Cause?
Acute myeloid leukaemia (366)
Febrile neutropenia (346)
Off label use (334)
Platelet count decreased (327)
Pneumonia (302)
Myelosuppression (300)
Pyrexia (281)
Death (206)
Product use issue (189)
Hepatic function abnormal (181)
What Other Drugs Cause Multiple organ dysfunction syndrome?
TACROLIMUS (1,847)
CYCLOPHOSPHAMIDE (1,597)
MYCOPHENOLATE MOFETIL (1,566)
PREDNISONE (1,525)
DEXAMETHASONE (1,355)
METHOTREXATE (1,317)
METHYLPREDNISOLONE (1,278)
RITUXIMAB (1,188)
PREDNISOLONE (1,154)
CYCLOSPORINE (933)
Which GILTERITINIB Alternatives Have Lower Multiple organ dysfunction syndrome Risk?
GILTERITINIB vs GIMERACIL\OTERACIL\TEGAFUR
GILTERITINIB vs GINKGO
GILTERITINIB vs GIVINOSTAT
GILTERITINIB vs GIVOSIRAN
GILTERITINIB vs GLASDEGIB